Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease

被引:72
|
作者
Zou, Yutong [1 ,2 ]
Zhao, Lijun [1 ,2 ]
Zhang, Junlin [1 ,2 ]
Wang, Yiting [1 ,2 ]
Wu, Yucheng [1 ,2 ]
Ren, Honghong [1 ,2 ]
Wang, Tingli [1 ,2 ]
Zhang, Rui [1 ,2 ]
Wang, Jiali [1 ,2 ]
Zhao, Yuancheng [1 ,2 ]
Qin, Chunmei [1 ,2 ]
Xu, Huan [3 ]
Li, Lin [3 ]
Chai, Zhonglin [4 ]
Cooper, Mark E. [4 ]
Tong, Nanwei [5 ]
Liu, Fang [1 ,2 ]
机构
[1] Sichuan Univ, Div Nephrol, West China Hosp, 37 Guoxue Alley, Chengdu 610041, Peoples R China
[2] Sichuan Univ, Ctr Diabet & Metab Res, Lab Diabet Kidney Dis, West China Hosp, Chengdu, Peoples R China
[3] Sichuan Univ, Div Pathol, West China Hosp, Chengdu, Peoples R China
[4] Monash Univ, Cent Clin Sch, Dept Diabet, Melbourne, Vic, Australia
[5] Sichuan Univ, Div Endocrinol, West China Hosp, Chengdu, Peoples R China
关键词
Type 2 diabetes mellitus; diabetic kidney disease; end-stage renal disease; risk prediction model; machine learning; ANEMIA; ACTIVATION; ALBUMIN;
D O I
10.1080/0886022X.2022.2056053
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims Diabetic kidney disease (DKD) is the most common cause of end-stage renal disease (ESRD) and is associated with increased morbidity and mortality in patients with diabetes. Identification of risk factors involved in the progression of DKD to ESRD is expected to result in early detection and appropriate intervention and improve prognosis. Therefore, this study aimed to establish a risk prediction model for ESRD resulting from DKD in patients with type 2 diabetes mellitus (T2DM). Methods Between January 2008 and July 2019, a total of 390 Chinese patients with T2DM and DKD confirmed by percutaneous renal biopsy were enrolled and followed up for at least 1 year. Four machine learning algorithms (gradient boosting machine, support vector machine, logistic regression, and random forest (RF)) were used to identify the critical clinical and pathological features and to build a risk prediction model for ESRD. Results There were 158 renal outcome events (ESRD) (40.51%) during the 3-year median follow up. The RF algorithm showed the best performance at predicting progression to ESRD, showing the highest AUC (0.90) and ACC (82.65%). The RF algorithm identified five major factors: Cystatin-C, serum albumin (sAlb), hemoglobin (Hb), 24-hour urine urinary total protein, and estimated glomerular filtration rate. A nomogram according to the aforementioned five predictive factors was constructed to predict the incidence of ESRD. Conclusion Machine learning algorithms can efficiently predict the incident ESRD in DKD participants. Compared with the previous models, the importance of sAlb and Hb were highlighted in the current model.
引用
收藏
页码:562 / 570
页数:9
相关论文
共 50 条
  • [31] Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes
    Zhao, Lijun
    Zou, Yutong
    Wu, Yucheng
    Cai, Linli
    Zhao, Yuancheng
    Wang, Yiting
    Xiao, Xiang
    Yang, Qing
    Yang, Jia
    Ren, Honghong
    Tong, Nanwei
    Liu, Fang
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [32] Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease
    Villar, E.
    Polkinghorne, K. R.
    Chang, S. H.
    Chadban, S. J.
    McDonald, S. P.
    DIABETOLOGIA, 2009, 52 (12) : 2536 - 2541
  • [33] Risk of Progression of Nonalbuminuric Diabetic Kidney Disease to End-Stage Renal Disease: The CRIC Study
    Koye, Digsu N.
    Magliano, Dianna J.
    Reid, Christopher M.
    Shaw, Jonathan E.
    DIABETES, 2017, 66 : A429 - A429
  • [34] The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus
    Postma, Maarten J.
    de Zeeuw, Dick
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (10) : 2975 - 2983
  • [35] Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients
    Zhao, Lijun
    Zou, Yutong
    Zhang, Junlin
    Zhang, Rui
    Ren, Honghong
    Lin, Li
    Guo, Ruikun
    Zhang, Jie
    Liu, Fang
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (14): : 2113 - 2124
  • [37] SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION IN PATIENTS WITH TYPE 2 DIABETIC END-STAGE RENAL DISEASE
    Kim, Young Hoon
    Park, Jae Berm
    Chung, Young Soo
    Song, Ki Byung
    Kim, Song-Cheol
    Han, Duck Jong
    TRANSPLANT INTERNATIONAL, 2011, 24 : 348 - 348
  • [38] Type II diabetes after combined kidney and pancreas transplantation for type I diabetes mellitus and end-stage renal disease
    Jones, JW
    Mizrahi, SS
    Bentley, FR
    CLINICAL TRANSPLANTATION, 1996, 10 (06) : 574 - 575
  • [39] Remnant cholesterol and the risk of diabetic nephropathy progression to end-stage kidney disease in patients with type 2 diabetes mellitus: a longitudinal cohort study
    Zhao, Yuancheng
    Liu, Ke
    Zou, Yutong
    Wu, Yucheng
    Yang, Jia
    Xiao, Xiang
    Ju, Xuegui
    Yang, Qin
    Lang, Yanlin
    Liu, Fang
    ENDOCRINE, 2024, 86 (03) : 994 - 1002
  • [40] RISK OF DEVELOPING END-STAGE RENAL DISEASE AFTER DIAGNOSIS OF TYPE 2 DIABETES
    Finne, Patrik
    Groop, Per-Henrik
    Arffman, Martti
    Kervinen, Marjo
    Helve, Jaakko
    Gronhagen-Riska, Carola
    Sund, Reijo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33